Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Thyroid Neoplasms 3Prostatic Neoplasms 3Lung Neoplasms 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Sarcoma, Synovial 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Liposarcoma 2Leukemia, Myeloid, Acute 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Tongue Neoplasms 1Tobacco Use Disorder 1Thyroid Nodule 1Thymus Neoplasms 1Testicular Neoplasms 1Skin Neoplasms 1Sarcoma, Kaposi 1Salivary Gland Neoplasms 1

Interventions

Standard of Care 8Surveys and Questionnaires 7COVID-19 Vaccines 6Blood Specimen Collection 6BNT162 Vaccine 6Specimen Handling 52019-nCoV Vaccine mRNA-1273 5Hydroxychloroquine 4Surgical Procedures, Operative 3Practice Guidelines as Topic 3tocilizumab 2sotrovimab 2sinovac COVID-19 vaccine 2cilgavimab and tixagevimab drug combination 2Sodium Chloride 2Pandemic Preparedness 2Data Collection 2CVnCoV COVID-19 vaccine 2COH04S1 COVID-19 vaccine 2Azithromycin 2selinexor 1remdesivir 1regorafenib 1proxalutamide 1palbociclib 1ogalvibart 1monalizumab 1lenzilumab 1heterologous prime boost COVID-19 vaccination 1crexavibart 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
COVID-19 × Molecular Diagnostic Techniques × Clear all
NCT04377802 2020-05-06

Safe Return to Regular Clinical Operation After COVID-19 Pandemic

King Fahad Specialist Hospital Dammam

Phase NA Unknown
400 enrolled

COVID-19

Data powered by HemOnc (CC BY 4.0) Colophon âš¡